RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Marketable securities, current

AbbVie Inc.ABBV

Market cap
$409.5B
P/E ratio
SummaryFinancials
Period EndMarketable securities, current (Million USD)YoY (%)
Dec 31, 202431+1450.00%
Dec 31, 20232-92.86%
Dec 31, 202228-66.67%
Dec 31, 202184+180.00%
Dec 31, 202030-96.11%
Dec 31, 2018772+58.85%
Dec 31, 2017486-63.27%
Dec 31, 20161,323+16437.50%
Dec 31, 20158-69.23%
Dec 31, 201426-91.33%
Dec 31, 2013300

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)